Novel Coronavirus (SARS-CoV-2/COVID-19)
The Food and Drug Administration will allow undiluted frozen vials of the Pfizer COVID-19 vaccine to be transported and stored at conventional pharmaceutical freezer temperatures (-13°F to 5°F) for up to two weeks as an alternative to its preferred storage at -112 F to -76ºF, the agency announced…
For the last few weeks, we’ve used this space to highlight the need for the next COVID-19 relief package to provide hospitals and health systems with additional resources and support so they can continue to care for patients and protect communities.
President Biden continued the national emergency for the COVID-19 pandemic beyond March 1.
The AHA and eight other hospital organizations urged Senate leaders to include additional COVID-19 relief funding for health care providers in the current reconciliation package.
The AHA along with eight other health organizations urge Congress to provide additional funding for health care providers in the current reconciliation package.
During an AHA virtual briefing for lawmakers and staff, leaders from three health systems — One Brooklyn Health System, Grady Health System, and The Hospitals of Providence, part of Tenet Healthcare — discussed the impact the COVID-19 pandemic is having on communities of color and how their health…
During a Feb. 23 AHA Advocacy Day briefing, AHA provided hospital and health system leaders with the latest intelligence from Capitol Hill and the information they need to make the case to lawmakers for additional COVID-19 relief.
The Food and Drug Administration's Office of Minority Health and Health Equity released two videos on COVID-19 vaccines and the importance of communities of color who have been disproportionately impacted by COVID-19 getting vaccinated to protect themselves and loved ones from the virus.
The AHA has received $6 million in grants from the Centers for Disease Control and Prevention to promote clinician and public confidence in COVID-19 vaccines, and help train current and future health care personnel to prevent and control infectious disease.
Data submitted to the Food and Drug Administration confirms that Johnson & Johnson’s COVID-19 vaccine candidate is safe and effective.